Aug 20, 2018
amras Vision, a North-Carolina base company developing a novel ocular implant to address refractory glaucoma, is the latest example of fundraising success among winners of Southeast BIO’s Early Stage Competition-…
May 5, 2018
DURHAM — Camras Vision Inc, a glaucoma treatment device startup that just completed funding of $5.7 million, will be seeking a Series B funding in 2019 of approximately $15 million. The…